Notify me when Stephen Boyd Wiles files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CLSD | Clearside Biomedical, Inc. | Common Stock, $0.001 par value | 5.2% | $3,362,985 | 4,003,553 | Stephen Boyd Wiles | 31 Mar 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|